Here's a taste of a workshop exploring meaningful consumer engagement in Cochrane, from Cochrane UK and Cochrane Ireland's 2019 symposium.
Sarah Chapman looks at Cochrane evidence on interventions for dysphagia in people with dementia and after stroke.
Sarah Chapman looks at new Cochrane evidence on two treatments for hip and knee osteoarthritis: paracetamol and exercise.
In this blog for people who have just stopped smoking Robert Walton, a general practitioner, helps you work out how best to stay smoke-free.
Which drug is most effective and safe in preventing postpartum haemorrhage. Four authors of a Cochrane network meta-analysis on uterotonic drugs share their findings in this blog.
Sarah Chapman looks at Cochrane evidence on the benefits and harms of pregabalin for neuropathic pain and reflects on experience of finding a balance between them.
In this blog for our Understanding Evidence series, Emma Carter and Selena Ryan-Vig share resources to help you get to grips with some key concepts that can help us to think critically about treatment claims.
Cochrane Co-ordinating Editor and review author Helen Handoll talks about new evidence that exercise prevents falls in older people and what it might mean for her mother and others like her.
In this blog, Beatriz Goulao shares news of the latest evidence on routine scale and polish and dental check-ups, and reflects on the more complicated story that emerges when finding out what people value.
Lynda Ware looks at the latest Cochrane evidence on different treatments for wrist fractures in children.
In this blog for a non-medical audience, Alastair Lamb and Altan Omer look at the evidence for use of PDE5 inhibitors (Viagra, Cialis & Levitra) for penile rehabilitation after prostate cancer surgery.
Sarah Chapman looks at the latest evidence on vitamin and mineral supplements for preventing dementia or at least slowing cognitive decline. Can they really help?